Biogen Alzheimer’s drug and the battle over dementia treatment of the future - CNBC

1. Biogen Alzheimer’s drug and the battle over dementia treatment of the future  CNBC
2. Cramer on FDA resignations in connection with approval of Biogen's Alzheimer's drug  CNBC Television
3. 3 Experts Quit An FDA Panel Over Alzheimer's Drug Approval  NPR
4. The debate over the FDA-approved Alzheimer’s drug showcases our system’s skewed priorities  The Washington Post
5. The Alzheimer’s economy: is the new $56,000-a-year drug worth it?  Financial Times
6. View Full Coverage on Google News

from Top stories - Google News https://ift.tt/eA8V8J